P

Inventor

RODGERS JAMES D

US82 patents
⚠️ This page may combine multiple inventors who share the name “RODGERS JAMES D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INCYTE CORP

29 patents
US9079912B2Jul 14, 2015

Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as Janus kinase inhibitors

INCYTE CORP75 citations99
US8829013B1Sep 9, 2014

Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

INCYTE CORP91 citations99
US8822481B1Sep 2, 2014

Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

INCYTE CORP89 citations99
US8741895B2Jun 3, 2014

Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors

INCYTE CORP84 citations99
US8722693B2May 13, 2014

Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

INCYTE CORP143 citations99
US8053433B2Nov 8, 2011

Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors

INCYTE CORP107 citations99
US7598257B2Oct 6, 2009

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors

INCYTE CORP328 citations99
US7335667B2Feb 26, 2008

Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-4-yl-amines as Janus kinase inhibitors

INCYTE CORP149 citations99
US10639310B2May 5, 2020

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

INCYTE CORP20 citations98
US10398699B2Sep 3, 2019

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors

INCYTE CORP31 citations98
US9974790B2May 22, 2018

Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitors

INCYTE CORP40 citations98
US9662335B2May 30, 2017

Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitors

INCYTE CORP25 citations98
US9623029B2Apr 18, 2017

3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane- or heptane-nitrile as JAK inhibitors

INCYTE CORP44 citations98
US9376439B2Jun 28, 2016

Salts of the janus kinase inhibitor (R)-3(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

INCYTE CORP62 citations98
US9227985B2Jan 5, 2016

Tricyclic heterocycles as bet protein inhibitors

INCYTE CORP40 citations98
US9216984B2Dec 22, 2015

3-[4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane—or heptane-nitrile as JAK inhibitors

INCYTE CORP56 citations98
US9206187B2Dec 8, 2015

Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as Janus kinase

INCYTE CORP55 citations98
US9090611B2Jul 28, 2015

Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors

INCYTE CORP60 citations98
US8933086B2Jan 13, 2015

Heteroaryl substituted pyrrolo[2,3-B]pyridines and pyrrolo[2,3-B]pyrimidines as Janus kinase inhibitors

INCYTE CORP71 citations98
US9334274B2May 10, 2016

N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors

INCYTE CORP57 citations97
US8841318B2Sep 23, 2014

Substituted heterocycles as janus kinase inhibitors

INCYTE CORP72 citations97
US8835423B2Sep 16, 2014

Azepine inhibitors of janus kinases

INCYTE CORP71 citations97
US7834022B2Nov 16, 2010

Metabolites of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

INCYTE CORP141 citations95
US11331320B2May 17, 2022

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

INCYTE CORP12 citations94
US10640506B2May 5, 2020

Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidines derivatives as JAK inhibitors

INCYTE CORP19 citations94
US10464947B2Nov 5, 2019

Tricyclic heterocycles as BET protein inhibitors

INCYTE CORP17 citations94
US10442803B2Oct 15, 2019

Tricyclic heterocycles as bet protein inhibitors

INCYTE CORP17 citations94
US9938294B2Apr 10, 2018

Tricyclic heterocycles as BET protein inhibitors

INCYTE CORP24 citations94
US9309246B2Apr 12, 2016

Tricyclic heterocycles as BET protein inhibitors

INCYTE CORP33 citations94

RODGERS JAMES D

15 patents
US8530485B2Sep 10, 2013

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

RODGERS JAMES D98 citations99
US8445488B2May 21, 2013

Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors

RODGERS JAMES D98 citations99
US8158616B2Apr 17, 2012

Azetidine and cyclobutane derivatives as JAK inhibitors

RODGERS JAMES D170 citations99
US9359358B2Jun 7, 2016

Cyclohexyl azetidine derivatives as JAK inhibitors

RODGERS JAMES D81 citations98
US9034884B2May 19, 2015

Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors

RODGERS JAMES D91 citations98
US8946245B2Feb 3, 2015

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

RODGERS JAMES D70 citations98
US8933085B2Jan 13, 2015

Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors

RODGERS JAMES D96 citations98
US8541425B2Sep 24, 2013

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

RODGERS JAMES D92 citations98
US8420629B2Apr 16, 2013

Azetidine and cyclobutane derivatives as JAK inhibitors

RODGERS JAMES D105 citations98
US8415362B2Apr 9, 2013

Pyrazolyl substituted pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

RODGERS JAMES D117 citations98
US8889697B2Nov 18, 2014

Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

RODGERS JAMES D79 citations97
US8716303B2May 6, 2014

N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors

RODGERS JAMES D109 citations97
US8486902B2Jul 16, 2013

Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

RODGERS JAMES D125 citations97
US8748401B2Jun 10, 2014

Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

RODGERS JAMES D80 citations96
US9249145B2Feb 2, 2016

Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors

RODGERS JAMES D45 citations94

LI YUN-LONG

2 patents

ARVANITIS ARGYRIOS G

2 patents

ZHOU JIACHENG

1 patent

DU PONT PHARM CO

1 patent

Showing the top 50 of 82 patents by PatentIndex Score.